Health insurance covers Torisel

Published: 2011-06-03 06:57:00

Updated: 2011-06-03 06:57:00

From June 1, patients with advanced renal cell carcinoma (RCC) may be reimbursed by national health insurance, when they are treated with Wyeth’s Torisel (temsilorimus).

Wyeth Korea said Tuesday that Torisel will be prescribed as the first-line drug for treatment of metastatic renal cancer.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK